NewsRx

Search our medical news database

Ovarian Cancer (Therapy)

Disease Succumbs to Antibody-Targeted Gene Therapy

Published in Women's Health Weekly, February 19th, 1996

Antibody-targeted, adenoviral-mediated gene transduction kills ovarian cancer cells expressing the oncogene erbB-2 in vivo.

Overexpression of the erbB-2 tyrosine kinase receptor plays a major role in the neoplastic transformation and progression of several epithelial malignancies including breast, lung, stomach and ovary. In breast and ovarian carcinoma, overexpression of erbB-2 correlates with an aggressive tumor with poor clinical outcome.

In vitro studies have shown that blocking overexpression of the erbB-2 oncogene inhibits cancer growth. Jessy Deshane et al. developed an alternative method of knocking out the erbB-2 oncoprotein ("Targeted...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Women's Health Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook